(Q37851395)

24 August 2017

1 reference

title

Is fibroblast growth factor 23 a harbinger of mortality in CKD? (English)

1 reference

24 August 2017

Jason R Stubbs

1

1 reference

24 August 2017

Steve Egwuonwu

series ordinal

2

1 reference

24 August 2017

publication date

10 March 2011

1 reference

24 August 2017

1 reference

24 August 2017

volume

27

1 reference

24 August 2017

issue

5

1 reference

24 August 2017

page(s)

697-703

1 reference

https://scigraph.springernature.com/pub.10.1007/s00467-011-1810-4

24 August 2017

exact match

0 references

cites work

Definition, evaluation, and classification of renal osteodystrophy: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO)

1 reference

https://api.crossref.org/works/10.1007%2FS00467-011-1810-4

Mineral metabolism, mortality, and morbidity in maintenance hemodialysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-011-1810-4

Association of serum phosphorus and calcium x phosphate product with mortality risk in chronic hemodialysis patients: a national study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-011-1810-4

Autosomal dominant hypophosphataemic rickets is associated with mutations in FGF23

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-011-1810-4

Pathogenic role of Fgf23 in Hyp mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-011-1810-4

Regulation of fibroblastic growth factor 23 expression but not degradation by PHEX.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-011-1810-4

Vitamin D receptor in chondrocytes promotes osteoclastogenesis and regulates FGF23 production in osteoblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-011-1810-4

Regulation of fibroblast growth factor 23 production in bone in uremic rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-011-1810-4

Identification of a novel fibroblast growth factor, FGF-23, preferentially expressed in the ventrolateral thalamic nucleus of the brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-011-1810-4

Effect of hydrolysis-resistant FGF23-R179Q on dietary phosphate regulation of the renal type-II Na/Pi transporter

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-011-1810-4

FGF-23 is a potent regulator of vitamin D metabolism and phosphate homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-011-1810-4

FGF23 fails to inhibit uremic parathyroid glands

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-011-1810-4

Loss of DMP1 causes rickets and osteomalacia and identifies a role for osteocytes in mineral metabolism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-011-1810-4

Phosphorylated acidic serine-aspartate-rich MEPE-associated motif peptide from matrix extracellular phosphoglycoprotein inhibits phosphate regulating gene with homologies to endopeptidases on the X-chromosome enzyme activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-011-1810-4

A novel GALNT3 mutation in a pseudoautosomal dominant form of tumoral calcinosis: evidence that the disorder is autosomal recessive

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-011-1810-4

Polypeptide GalNAc-transferase T3 and familial tumoral calcinosis. Secretion of fibroblast growth factor 23 requires O-glycosylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-011-1810-4

FGF23 is processed by proprotein convertases but not by PHEX.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-011-1810-4

Isolated C-terminal tail of FGF23 alleviates hypophosphatemia by inhibiting FGF23-FGFR-Klotho complex formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-011-1810-4

Fibroblast growth factor-23 relationship to dietary phosphate and renal phosphate handling in healthy young men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-011-1810-4

Fibroblast growth factor 23 is a counter-regulatory phosphaturic hormone for vitamin D.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-011-1810-4

Regulation of fibroblast growth factor-23 signaling by klotho

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-011-1810-4

Klotho converts canonical FGF receptor into a specific receptor for FGF23

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-011-1810-4

Secreted Klotho protein in sera and CSF: implication for post-translational cleavage in release of Klotho protein from cell membrane

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-011-1810-4

Mutation of the mouse klotho gene leads to a syndrome resembling ageing

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-011-1810-4

Sinoatrial node dysfunction and early unexpected death of mice with a defect of klotho gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-011-1810-4

Pilot study of dietary phosphorus restriction and phosphorus binders to target fibroblast growth factor 23 in patients with chronic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-011-1810-4

Severely reduced production of klotho in human chronic renal failure kidney.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-011-1810-4

Dysregulation of renal vitamin D metabolism in the uremic rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-011-1810-4

Serum fibroblast growth factor-23 levels predict the future refractory hyperparathyroidism in dialysis patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-011-1810-4

Fibroblast growth factor-23 and early decrements in kidney function: the Heart and Soul Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-011-1810-4

Fibroblast growth factor 23 and mortality among patients undergoing hemodialysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-011-1810-4

Serum intact FGF23 associate with left ventricular mass, hypertrophy and geometry in an elderly population

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-011-1810-4

The associations of fibroblast growth factor 23 and uncarboxylated matrix Gla protein with mortality in coronary artery disease: the Heart and Soul Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-011-1810-4

The FGF family: biology, pathophysiology and therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-011-1810-4

Clinical epidemiology of cardiovascular disease in chronic kidney disease prior to dialysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-011-1810-4

Activated injectable vitamin D and hemodialysis survival: a historical cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-011-1810-4

Impact of activated vitamin D and race on survival among hemodialysis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-011-1810-4

Fibroblast growth factor 23 and left ventricular hypertrophy in chronic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-011-1810-4

Fibroblast growth factor 23: a possible cause of left ventricular hypertrophy in hemodialysis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-011-1810-4

Relation between plasma fibroblast growth factor-23, serum fetuin-A levels and coronary artery calcification evaluated by multislice computed tomography in patients with normal kidney function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-011-1810-4

Peripheral vascular calcification in long-haemodialysis patients: associated factors and survival consequences

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-011-1810-4

Relationship between circulating FGF23 and total body atherosclerosis in the community

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-011-1810-4

Fibroblast growth factor-23 (FGF-23) is independently correlated to aortic calcification in haemodialysis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-011-1810-4

Fibroblast growth factor 23 and fetuin A are independent predictors for the coronary artery disease extent in mild chronic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-011-1810-4

Impact of fibroblast growth factor 23 on lipids and atherosclerosis in hemodialysis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-011-1810-4

FGF-23 and vascular dysfunction in patients with stage 3 and 4 chronic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-011-1810-4

High levels of serum fibroblast growth factor (FGF)-23 are associated with increased mortality in long haemodialysis patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-011-1810-4

FGF-23 and future cardiovascular events in patients with chronic kidney disease before initiation of dialysis treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-011-1810-4

Parathyroid hormone regulates fibroblast growth factor-23 in a mouse model of primary hyperparathyroidism

21 January 2018

1 reference

12 December 2020

Plasma fibroblast growth factor-23 levels are independently associated with carotid artery atherosclerosis in maintenance hemodialysis patients

1 reference

12 December 2020

Involvement of SOX-9 and FGF-23 in RUNX-2 regulation in osteoarthritic chondrocytes

1 reference

12 December 2020

Regulation of C-terminal and intact FGF-23 by dietary phosphate in men and women

1 reference

12 December 2020

The parathyroid is a target organ for FGF23 in rats

1 reference

12 December 2020

Fibroblast Growth Factor 23 (FGF23) Predicts Progression of Chronic Kidney Disease: The Mild to Moderate Kidney Disease (MMKD) Study

1 reference

12 December 2020

Peripheral artery calcifications evaluated by histology correlate to those detected by CT: relationships with fetuin-A and FGF-23

1 reference

12 December 2020

Arterial calcifications, arterial stiffness, and cardiovascular risk in end-stage renal disease

1 reference

12 December 2020

Clinical variability of familial tumoral calcinosis caused by novel GALNT3 mutations

1 reference

12 December 2020

Serum osteoprotegerin is a predictor of progression of atherosclerosis and coronary calcification in hemodialysis patients

1 reference

12 December 2020

Circulating fibroblast growth factor-23 is associated with vascular dysfunction in the community

1 reference

12 December 2020

Vascular calcification and 25-hydroxyvitamin D levels in non-dialysis patients with chronic kidney disease stages 4 and 5.

1 reference

12 December 2020

Serum fibroblast growth factor-23 (FGF-23) levels are independently associated with left ventricular mass and myocardial performance index in maintenance haemodialysis patients

1 reference

12 December 2020

Association between fibroblast growth factor 23 and left ventricular hypertrophy in maintenance hemodialysis patients. Comparison with B-type natriuretic peptide and cardiac troponin T

1 reference

12 December 2020

Chronic kidney disease and the risk for cardiovascular disease, renal replacement, and death in the United States Medicare population, 1998 to 1999

1 reference

12 December 2020

Fibroblast growth factor 23 in chronic kidney disease: bridging the gap between bone mineral metabolism and left ventricular hypertrophy

1 reference

12 December 2020

Direct evidence for a causative role of FGF23 in the abnormal renal phosphate handling and vitamin D metabolism in rats with early-stage chronic kidney disease

1 reference

12 December 2020

Vegetarian compared with meat dietary protein source and phosphorus homeostasis in chronic kidney disease

1 reference

12 December 2020

10.1007/S00467-011-1810-4

Identifiers

DOI

1 reference

24 August 2017

1 reference